Matches in SemOpenAlex for { <https://semopenalex.org/work/W170630882> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W170630882 endingPage "83" @default.
- W170630882 startingPage "79" @default.
- W170630882 abstract "A new antiviral and immunomodulating preparation Viferon, produced as rectal suppositories containing recombinant alpha-2b-interferon (IFN) and antioxidants, was used in complex therapy of viral chronic hepatitides B and C (ChHB and ChHC) in children. Results of our investigation showed a high efficiency of Viferon. Viferon was found to suppress replication of hepatotropic viruses and to decrease activity of the pathologic process in the liver of children with ChHB and ChHC. After a Viferon treatment with daily doses of (1-2) x 10(6) IU of IFN (3.0 x 10(6) IU/m2) primary remission was registered in 78% of patients with ChHB and in 44% of patients with ChHC, while lasting remission was found in 82% of ChHB and in 33% of ChHC patients. Thus, a more marked effect was observed with ChHB, in which 3.0 x 10(6) IU/m2 was the optimal daily dose for children. Increasing the dose to 5.0 x 10(6) IU/m2 did not result in rise of the percentage of the remissions. Side effects, which are characteristic for injection of IFN preparations, were never found even after a longterm treatment. Absence of induction of neutralizing antibodies was observed after administration of alpha-2b-IFN, an integral part of Viferon. In pediatrics, the method of rectal administration has advantages over parenteral delivery due to its convenience, non-traumatic character and possibility of use for prolonged periods." @default.
- W170630882 created "2016-06-24" @default.
- W170630882 creator A5015592135 @default.
- W170630882 creator A5016808612 @default.
- W170630882 creator A5025684025 @default.
- W170630882 creator A5028580264 @default.
- W170630882 creator A5031086240 @default.
- W170630882 creator A5033115497 @default.
- W170630882 creator A5041269815 @default.
- W170630882 creator A5050001908 @default.
- W170630882 creator A5067185556 @default.
- W170630882 creator A5067403742 @default.
- W170630882 date "2000-04-01" @default.
- W170630882 modified "2023-09-26" @default.
- W170630882 title "Use of recombinant alpha-2b-interferon in combination with antioxidants in the form of rectal suppositories (viferon) in children with chronic hepatitides B and C." @default.
- W170630882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10989698" @default.
- W170630882 hasPublicationYear "2000" @default.
- W170630882 type Work @default.
- W170630882 sameAs 170630882 @default.
- W170630882 citedByCount "1" @default.
- W170630882 crossrefType "journal-article" @default.
- W170630882 hasAuthorship W170630882A5015592135 @default.
- W170630882 hasAuthorship W170630882A5016808612 @default.
- W170630882 hasAuthorship W170630882A5025684025 @default.
- W170630882 hasAuthorship W170630882A5028580264 @default.
- W170630882 hasAuthorship W170630882A5031086240 @default.
- W170630882 hasAuthorship W170630882A5033115497 @default.
- W170630882 hasAuthorship W170630882A5041269815 @default.
- W170630882 hasAuthorship W170630882A5050001908 @default.
- W170630882 hasAuthorship W170630882A5067185556 @default.
- W170630882 hasAuthorship W170630882A5067403742 @default.
- W170630882 hasConcept C104317684 @default.
- W170630882 hasConcept C126322002 @default.
- W170630882 hasConcept C159654299 @default.
- W170630882 hasConcept C203014093 @default.
- W170630882 hasConcept C2776178377 @default.
- W170630882 hasConcept C2776873419 @default.
- W170630882 hasConcept C2781228144 @default.
- W170630882 hasConcept C2909179924 @default.
- W170630882 hasConcept C40767141 @default.
- W170630882 hasConcept C55493867 @default.
- W170630882 hasConcept C71924100 @default.
- W170630882 hasConcept C86803240 @default.
- W170630882 hasConcept C90924648 @default.
- W170630882 hasConceptScore W170630882C104317684 @default.
- W170630882 hasConceptScore W170630882C126322002 @default.
- W170630882 hasConceptScore W170630882C159654299 @default.
- W170630882 hasConceptScore W170630882C203014093 @default.
- W170630882 hasConceptScore W170630882C2776178377 @default.
- W170630882 hasConceptScore W170630882C2776873419 @default.
- W170630882 hasConceptScore W170630882C2781228144 @default.
- W170630882 hasConceptScore W170630882C2909179924 @default.
- W170630882 hasConceptScore W170630882C40767141 @default.
- W170630882 hasConceptScore W170630882C55493867 @default.
- W170630882 hasConceptScore W170630882C71924100 @default.
- W170630882 hasConceptScore W170630882C86803240 @default.
- W170630882 hasConceptScore W170630882C90924648 @default.
- W170630882 hasIssue "2" @default.
- W170630882 hasLocation W1706308821 @default.
- W170630882 hasOpenAccess W170630882 @default.
- W170630882 hasPrimaryLocation W1706308821 @default.
- W170630882 hasRelatedWork W2024479430 @default.
- W170630882 hasRelatedWork W2043108404 @default.
- W170630882 hasRelatedWork W2091337311 @default.
- W170630882 hasRelatedWork W2313378576 @default.
- W170630882 hasRelatedWork W2383557089 @default.
- W170630882 hasRelatedWork W2412431669 @default.
- W170630882 hasRelatedWork W2416088536 @default.
- W170630882 hasRelatedWork W2418841296 @default.
- W170630882 hasRelatedWork W3024866631 @default.
- W170630882 hasRelatedWork W2011949877 @default.
- W170630882 hasVolume "44" @default.
- W170630882 isParatext "false" @default.
- W170630882 isRetracted "false" @default.
- W170630882 magId "170630882" @default.
- W170630882 workType "article" @default.